Page last updated: 2024-09-03

gsk peptide and Liver Neoplasms

gsk peptide has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berry, DP; Doucas, H; Garcea, G; Manson, MM; Neal, CP1

Reviews

1 review(s) available for gsk peptide and Liver Neoplasms

ArticleYear
Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:3

    Topics: Axin Protein; beta Catenin; Carcinoma, Hepatocellular; Cyclin D1; Cytoskeletal Proteins; DNA-Binding Proteins; Frizzled Receptors; Gastrointestinal Neoplasms; Genes, APC; Genes, myc; Humans; Intercellular Signaling Peptides and Proteins; Liver Neoplasms; Matrix Metalloproteinase 7; Oligopeptides; Pancreatic Neoplasms; Prognosis; Proteins; Repressor Proteins; Signal Transduction; Trans-Activators; Wnt Proteins

2005